J.Safra Asset Management »

Royalty Pharma shares owned by J.Safra Asset Management

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by J.Safra Asset Management from 13F filings

Historical chart of J.Safra Asset Management investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by J.Safra Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by J.Safra Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $658 26 25.31
2024-09-30 $732 26 28.19
2022-12-31 $7.0k 194 36.08

More positions owned by J.Safra Asset Management

Invesco Qqq Tr Unit Ser 1 Unit Ser 1 (QQQ)
Select Sector Spdr Trust The Technology Select Sector Spdr Fund Technology (XLK)
Ishares Russell 1000 Growth Etf Rus 1000 Grw Etf (IWF)
Ishares Core S&p Small Cap Etf Core S&p Scp Etf (IJR)
Select Sector Spdr Trust The Financial Select Sector Spdr Fund Financial (XLF)
Select Sector Spdr Trust The Communication Services Select Sector Spdr Fund Communication (XLC)
Select Sector Spdr Trust Shs Ben Int Energy Energy (XLE)
Select Sector Spdr Trust The Health Care Select Sector Spdr Fund Sbi Healthcare (XLV)
Spdr S&p 500 Etf Trust Etf Tr Unit (SPY)
Spdr S&p Dividend Etf S&P Divid EFT (SDY)
Invesco Exchange Traded Fund Trust Invesco S&p 500 Equal Weight Etf S&p500 Eql Wgt (RSP)
Select Sector Spdr Trust The Industrial Select Sector Spdr Fund Indl (XLI)
Spdr Ser Tr S&p Ins Etf S&p Ins Etf (KIE)
Spdr Ser Tr S&p Biotech Etf S&P Biotech (XBI)
Vaneck Etf Tr Vaneck Semiconductor Etf Semiconductr Etf (SMH)

View all positions for J.Safra Asset Management

Top funds holding Royalty Pharma

Morgan Stanley
Vanguard Group
FMR
BlackRock
Adage Capital Partners GP
Baillie Gifford & Co
Viking Global Investors
Swedbank AB
State Street Corporation
Geode Capital Management
Norges Bank Investment Management
Two Sigma Advisers
Northern Trust
GMT Capital Corp
Deutsche Bank Aktiengesellschaft

View all funds holding Royalty Pharma